The goal of this study is to analyze the biological significance of the interferon and cytokine systems in SIV induced immunodeficiency syndrome. We have previously shown that interferon induced inhibition of murine leukemia virus (MuLV) replication occurs at the level of virus assembly and that the interferon treatment leads to a formation of defective particles. Our recent results show that HIV infection in T-cells is sensitive to the antiviral effect of interferon, however, whether the interferon induced block of HIV replication is identical to that seen with MuLV is not clear as yet. In addition, we have recently shown that in retrovirus induced murine immunodeficiency, the regulated expression of interferon genes is altered. In the present proposal, we shall use the SIV induced immunodeficiency model to examine the roles which interferons and cytokines associated with the interferon system (e.g. TNF, I1-1 and IL-6) play in the life- cycle and pathophysiology of SIV infection and examine the following questions: 1) What is the role of interferon and TNF in the SIV replication and induction of AIDS symptoms? Does the infection with SIV effect the inducible expression of the interferon genes and cytokines closely related to the interferon system (e.g. TNF, I1-1, beta 2 - IL-6)? Does the interferon system contribute to the suppression of SIV infection in vivo? or to SIV induced pathogenicity; 2) Does the SIV infection in monkey lead to the production a) of an acid-labile alpha-interferon, such as seen in AIDS patients or b) a novel acid-stable interferon that has been found to be induced by co-cultivation of visna virus infected macrophages with T-cells. If these two interferons can be induced in vitro system, they will be characterized on the RNA levels by using the available cloned DNA probe and on the protein levels with the available antibodies. If the analysis will indicate a novel interferon protein(s), the cDNA will be cloned and characterized. We believe that the SIV system will enable us to compare in molecular terms the effect of interferon in retroviral infection both in vitro and in vivo and allow us to evaluate the complex role of the cytokine system in retroviral infection and induce immunosuppression. These data should prove a firm production for the understanding of pathogenicity of HIV infection in AIDS syndrome in man.

Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Su, Y; Popik, W; Pitha, P M (1995) Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells. J Virol 69:110-21
Joag, S V; Stephens, E B; Adams, R J et al. (1994) Pathogenesis of SIVmac infection in Chinese and Indian rhesus macaques: effects of splenectomy on virus burden. Virology 200:436-46
Zhong, R K; Donnenberg, A D; Rubin, J et al. (1994) Differential effect of 4-hydroperoxycyclophosphamide and antimyeloid monoclonal antibodies on T and natural killer cells during bone marrow purging. Blood 83:2345-51
Joag, S V; Adams, R J; Pinson, D M et al. (1994) Intracerebral infusion of TNF-alpha and IL-6 failed to activate latent SIV infection in the brains of macaques inoculated with macrophage-tropic neuroadapted SIVmac. J Leukoc Biol 56:353-7
Clements, J E; Anderson, M G; Zink, M C et al. (1994) The SIV model of AIDS encephalopathy. Role of neurotropic viruses in diseases. Res Publ Assoc Res Nerv Ment Dis 72:147-57
Shirazi, Y; Popik, W; Pitha, P M (1994) Modulation of interferon-mediated inhibition of human immunodeficiency virus type 1 by Tat. J Interferon Res 14:259-63
Shirazi, Y; Pitha, P M (1993) Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells. Virology 193:303-12
Popik, W; Pitha, P M (1993) Role of tumor necrosis factor alpha in activation and replication of the tat-defective human immunodeficiency virus type 1. J Virol 67:1094-9
Joag, S V; Narayan, O (1993) Immunodeficiency-inducing retroviruses. Curr Opin Immunol 5:595-9
Anderson, M G; Hauer, D; Sharma, D P et al. (1993) Analysis of envelope changes acquired by SIVmac239 during neuroadaption in rhesus macaques. Virology 195:616-26

Showing the most recent 10 out of 30 publications